Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Maehlen, Marthe T ^a,b   Provan, Sella A ^b   de Rooy, Diederik P C ^c   van der Helm van Mil, Annette H M ^c   Krabben, Annemarie ^c   Saxne, Tore ^d   Lindqvist, Elisabet ^d   Semb, Anne Grete ^b   Uhlig, Till ^b   van der Heijde, Désirée ^b,c   Mero, Inger Lise ^a   Olsen, Inge C ^b   Kvien, Tore K ^b   Lie, Benedicte A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RHEUMATOID FACTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAND RADIOGRAPHY; HUMAN; JOINT INJURY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORWEGIAN; OUTCOME ASSESSMENT; RHEUMATOID ARTHRITIS;

ACUTE-PHASE REACTION; APOLIPOPROTEINS E; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JOINTS; LIPIDS; LONGITUDINAL STUDIES; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; NORWAY;

EID: 84876256693     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060970     Document Type: Article

References (44)

1. Marinou I, Maxwell JR, Wilson AG, (2010) Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann Rheum Dis. 69: 476-82.
2. van der Helm-van Mil AH, Kern M, Gregersen PK, Huizinga TW, (2006) Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. Arthritis Rheum. 54: 2028-30.
3. Odegard S, Landewe R, van der HD, Kvien TK, Mowinckel P, et al. (2006) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum. 54: 68-75.
4. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL, (2001) The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 44: 2009-17.
5. Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, et al. (2011) Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis. 70: 812-7.
6. Mahley RW, (1988) Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology. Science. 240: 622-630.
7. Bennet AM, Di AE, Ye Z, Wensley F, Dahlin A, et al. (2007) Association of Apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 298: 1300-11.
8. Zhang H, Wu LM, Wu J (2001) Cross-talk between Apolipoprotein E and Cytokines. Mediators Inflamm. DOI:10.1155/2011/949072.
9. Zhang HL, Wu J, Zhu J (2010) The Immune-Modulatory Role of Apolipoprotein E with Emphasis on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Clin Dev Immunol. DOI: 10.1155/2010/186813.
10. Mahley RW, Rall SC Jr, (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 1: 507-37.
11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261: 921-3.
12. Coto-Segura P, Coto E, Alvarez V, Morales B, Soto-Sanchez J, et al. (2009) Apolipoprotein epsilon 4 allele is associated with psoriasis severity. Arch Dermatol Res. 302: 145-9.
13. Furumoto H, Nakamura K, Imamura T, Hamamoto Y, Shimizu T, et al. (1997) Association of apolipoprotein allele epsilon 2 with psoriasis vulgaris in Japanese population. Arch Dermatol Res. 289: 497-500.
14. Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, et al. (2011) Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 54: 544-53.
15. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, et al. (2002) Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36: 456-63.
16. Hubacek JA, Peasey A, Pikhart H, Stavek P, Kubinova R, et al. (2010) APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum Immunol. 71: 304-8.
17. Toms TE, Smith JP, Panoulas VF, Blackmore H, Douglas KM, et al. (2012) Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis. J Rheumatol. 39: 218-25.
18. Postigo J, Genre F, Iglesias M, Fernandez-Rey M, Buelta L, et al. (2011) Exacerbation of type II collagen-induced arthritis in apolipoprotein E-deficient mice in association with the expansion of Th1 and Th17 cells. Arthritis Rheum. 63: 971-80.
19. Belbin O, Dunn JL, Ling Y, Morgan L, Chappell S, et al. (2007) Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. Hum Mol Genet. 16: 2199-208.
20. Toms TE, Panoulas VF, Kitas GD, (2011) Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J. 5: 64-75.
21. Stevens RJ, Douglas KM, Saratzis AN, Kitas GD, (2005) Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med. 7 (7): 1-24.
22. Syversen SW, Gaarder PI, Goll GL, Odegaard S, Haavardsholm EA, et al. (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 67: 212-7.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-24.
24. Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK, (2008) Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 67: 794-800.
25. Uhlig T, Kvien TK, Jensen JL, Axell T, (1999) Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis. 58: 415-22.
26. Halvorsen EH, Haavardsholm EA, Pollmann S, Boonen A, van der Heijde D, et al. (2009) Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis. 68: 249-52.
27. Provan SA, Angel K, Semb AG, Mowinckel P, Agewall S, et al. (2010) Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year follow up study of 108 patients with rheumatoid arthritis. J Rheumatol 38: 606-12.
28. Semb AG, Rollefstad S, Provan SA, Kvien TK, Stranden E, et al. (2012) Carotid plaque characteristics are associated with disease activity in rheumatoid arthritis. Rheumatology. in press.
29. van der Heijde D, (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 27: 261-3.
30. Fex E, Jonsson K, Johnson U, Eberhardt K, (1996) Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol. 35: 1106-15.
31. de Rooy DP, van der Linden MP, Knevel R, Huizinga TWJ, van der Helm-van Mil AHM, (2011) Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology. (Oxford) 50: 93-100.
32. Akaike H, (1974) A new look at the statistical model identification. IEEE Tran. Autom. Control. 19: 716-723.
33. Hsu JC, (1992) The Factor Analytic Approach to Simultaneous Inference in the General Linear Model. J. Comput. Graph. Stat.1: 151-168.
34. Sidak Z, (1967) Rectangular Confidence Regions for the Means of Multivariate Normal Distributions. J Am Statist Assoc. 62: 626-633.
35. Knevel R, Krabben A, Brouwer E, Posthumus MD, Wilson AG, et al. (2012) Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis. 71: A56-A57.
36. Lebrec JJ, Stijnen T, van Houwelingen HC (2010) Dealing with heterogeneity between cohorts in genome wide SNP association studies. Stat Appl Genet Mol Biol. 9: Article 8.
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 81: 559-75.
38. Dupont WD, Plummer WD Jr, (1990) Power and sample size calculations. A review and computer program. Control Clin Trials. 11: 116-28.
39. Klareskog L, Catrina AI, Paget S, (2009) Rheumatoid arthritis. Lancet. 373: 659-72.
40. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, et al. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992. Circulation. 19: 237-42.
41. Slooter AJ, Bots ML, Havekes LM, Iglesias del Sol A, Cruts M, et al. (2001) Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study. Stroke. 32: 1947-52.
42. de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH, (2011) Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford). 50: 93-100.
43. van der Helm-van Mil AH, Knevel R, van der Heijde D, Huizinga TW, (2010) How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis? Rheumatology (Oxford). 49: 1429-35.
44. Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, et al. (2012) Exercise Engagement as a Moderator of the effects of APOE Genotype on Amyloid Deposition. Arch Neurol. 69: 636-643.